Joint Corp(JYNT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 6:20 PM ET (Korea 9/12 07:20)
Full metrics table
| Index | - | P/E | 30.09 | EPS (ttm) | 0.26 | Insider Own | 16.23% | Shs Outstand | 14.2M | Perf Week | -5.19% |
| Market Cap | 0.11B | Forward P/E | 19.96 | EPS next Y | 63.89% | Insider Trans | 5.91% | Shs Float | 11.8M | Perf Month | -9.56% |
| Enterprise Value | 0.09B | PEG | - | EPS next Q | 0.08 | Inst Own | 68.45% | Short Float | 3.37% | Perf Quarter | -13.74% |
| Income | 0.00B | P/S | 1.9 | EPS this Y | 1300% | Inst Trans | -7.16% | Short Ratio | 3.85 | Perf Half Y | -4.38% |
| Sales | 0.06B | P/B | 7.03 | EPS next 5Y | - | ROA | 3.33% | Short Interest | 0.40M | Perf YTD | -9.98% |
| Book/sh | 1.12 | P/C | 4.83 | EPS past 3/5Y | 64.32% -26.62% | ROE | 10.64% | 52W High | -26.43% ($10.67) | Perf Year | -23.04% |
| Cash/sh | 1.63 | P/FCF | 26.25 | Sales past 3/5Y | -18.46% -1.33% | ROIC | 21.65% | 52W Low | 4.67% ($7.50) | Perf 3Y | -17.97% |
| Dividend Est. | - | EV/EBITDA | 17.03 | EPS Y/Y TTM | 285.78% | Gross Margin | 78.82% | Volatility(W/M) | 1.9% 2.81% | Perf 5Y | -92.58% |
| Dividend TTM | - | EV/Sales | 1.54 | Sales Y/Y TTM | -17.84% | Oper. Margin | 6.1% | ATR (14) | 0.25 | Perf 10Y | 179.36% |
| Dividend Ex-Date | - | Quick Ratio | 1.79 | EPS Q/Q | 650.82% | Profit Margin | 6.49% | RSI (14) | 31.71 | Recom | 2.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.79 | Sales Q/Q | 14.41% | SMA20 | -5.64% ($8.32) | Beta | 1.08 | Target Price | $10 |
| Payout | - | Debt/Eq | 0.13 | Earnings | 2026/8/6 | SMA50 | -7.93% ($8.53) | Rel Volume | 0.93 | Prev Close | $8.03 |
| Employees | 330 | LT Debt/Eq | 0.11 | EPS/Sales Surpr. | -121.41% 4.18% | SMA200 | -10.94% ($8.81) | Avg Volume(3M) | 0.10M | Price | $7.85 |
| IPO | 2014/11/11 | Option/Short | Yes/Yes | Trades | 1550 | Volume | 96,962 | Change | -2.24% |
Company
JYNT is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🦴 The Joint Corp. (JYNT) is a U.S. healthcare company that operates chiropractic clinics under "The Joint Chiropractic" brand. It runs a membership- and subscription-based care model that lets patients walk in without an appointment or insurance, and it has grown into an ultra-small-footprint healthcare service company by expanding most of its locations through franchising.
Over the past 1 year, on the lower side
26% below its 1-year high.
JYNT makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +1300.0% this year.
Tap to view numbers
But it is not cheap
Trading at 30.1 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -18.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 68.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IWC 0.00%
GSSC 0.00%
SMLF 0.00%
AVUV 0.00%
DFAC 0.00%It ranks #4 in the industry
Based on market cap of $111M.
JYNT $111M PER 30.1
HCA $92B PER 14.3
THC $21B PER 10.2
EHC $12B PER 19.8
FAQ
What kind of company is JYNT?
JYNT belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of JYNT?
The market cap of JYNT is approximately $111M, ranking 4,499 within its sector.
What is the P/E ratio of JYNT?
JYNT has a P/E ratio of approximately 30.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for JYNT?
JYNT has recorded a 52-week high of $10.67 and a low of $7.50.
